Is Poor Glycemic Control Associated with Reduced Red Blood Cell Lifespan?

Diabetes Care

Volumn 27, Issue 4, 2004, Pages 1013-1014

  Cohen, Robert M ^a,b   Franco, Robert S ^a,c   Joiner, Clinton H ^a,c  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; ERYTHROCYTE CR 51; HEMOGLOBIN A1C;

CARBON MONOXIDE BLOOD LEVEL; DIABETES MELLITUS; EDITORIAL; ERYTHROCYTE LIFESPAN; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN;

ERYTHROCYTE AGING; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MODELS, CARDIOVASCULAR;

EID: 1842433541     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.4.1013     Document Type: Editorial

References (9)

1. Virtue MA, Furne JK, Nuttall FQ, Levitt MD: Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration. Diabetes Care 27:931-935, 2004
2. Strocchi, A, Schwartz, S, Ellefson, M, Engel, RR, Medina, A, Levitt, MD: A simple carbon monoxide breath test to estimate erythrocyte turnover. J Lab Clin Med 120: 392-399, 1992
3. Furne JK, Springfield JR, Ho SB, Levitt MD: Simplification of the end-alveolar carbon monoxide technique to assess erythrocyte survival. J Lab Clin Med 142: 52-57, 2003
4. Franco RS, Lohmann J, Silberstein EB, Mayfield-Pratt G, Palascak M, Nemeth TA, Joiner CH, Weiner M, Rucknagel DL: Time-dependent changes in the density and hemoglobin F content of biotin-labeled sickle cells. J Clin Invest 101:2730-2740, 1998
5. Mock DM, Lankford GL, Widness JA, Burmeister LF, Kahn D, Strauss RG: Measurement of red cell survival using biotin-labeled red cells: validation against 51Cr-labeled red cells. Transfusion 39:156-162, 1999
6. Peterson CM, Jones RL, Koenig RJ, Melvin ET, Lehrman ML: Reversible hematologic sequelae of diabetes mellitus. Ann Intern Med 86:425-429, 1977
7. 1c levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins. Diabetes 50:2858-2863, 2001
8. McCarter R, Hempe J, Gomez R, Chalew SA: He̊moglobin glycosylation index is a predictor of complications in the DCCT (Abstract). Diabetes 49 (Suppl. 1):A48, 2000
9. 1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy. Diabetes Care 26:163-167, 2003